low
monocyt
hladr
express
wide
use
marker
innat
immun
suppress
critic
ill
patient
recent
show
bacteri
septic
shock
patient
low
mhladr
express
preval
associ
develop
secondari
infect
end
march
excess
confirm
case
coronaviru
diseas
worldwid
netherland
sever
report
suggest
patient
sever
may
suffer
hyperinflammatori
cytokin
storm
howev
unlik
sarscov
infect
high
level
antiinflammatori
mediat
eg
also
report
although
indic
secondari
infect
common
patient
one
studi
report
patient
die
develop
secondari
infect
might
indic
immunesuppress
state
herein
explor
mhladr
express
kinet
cohort
critic
ill
patient
march
th
th
patient
admit
intens
care
unit
icu
includ
prospect
observ
studi
confirm
two
posit
rtpcr
test
throat
swab
ctscan
find
fourteen
patient
transfer
icu
median
icu
length
stay
time
studi
inclus
day
studi
carri
accord
applic
rule
concern
review
research
ethic
committe
inform
consent
netherland
ethic
committe
cmo
arnhemnijmegen
board
waiv
need
inform
consent
observ
natur
studi
noninvas
blood
withdraw
patient
arteri
canula
place
venapunctur
perform
patient
legal
repres
inform
studi
detail
allow
abstain
particip
ethylenediaminetetraacet
acid
edta
anticoagul
blood
store
c
mhladr
express
analysi
perform
within
hour
withdraw
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
characterist
list
tabl
line
previou
observ
major
patient
male
mani
comorbid
median
time
onset
symptom
icu
admiss
day
patient
mechan
ventil
exhibit
increas
inflammatori
paramet
tabl
march
th
two
patient
die
day
posticu
admiss
data
one
timepoint
patient
record
patient
still
icu
although
mhladr
express
level
patient
lower
observ
healthi
subject
mabcel
extent
suppress
less
pronounc
observ
bacteri
septic
shock
patient
figur
sepsi
data
mhladr
express
kinet
reveal
chang
time
figur
circul
creactiv
protein
concentr
declin
time
figur
wherea
signific
chang
circul
procalcitonin
leukocyt
ferritin
level
observ
figur
f
none
patient
develop
secondari
infect
conclus
despit
pronounc
inflammatori
respons
patient
preliminari
result
indic
moder
innat
immun
suppress
compar
bacteri
septic
shock
patient
find
accord
low
incid
secondari
infect
patient
therefor
innat
immun
suppress
neg
feedback
mechan
follow
pathogenassoci
molecular
patterninduc
inflamm
appear
less
pronounc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
secondari
infect
death
data
obtain
studi
inclus
present
n
median
iqr
chronic
use
immunosuppress
medic
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
studi
carri
accord
applic
rule
concern
review
research
ethic
committe
inform
consent
netherland
ethic
committe
cmo
arnhemnijmegen
board
waiv
need
inform
consent
observ
natur
studi
noninvas
blood
withdraw
patient
arteri
canula
place
venapunctur
perform
patient
legal
repres
inform
studi
detail
could
abstain
particip
applic
data
gener
analys
studi
includ
publish
articl
author
declar
compet
interest
work
intern
fund
particip
depart
bacteri
septic
shock
day
andor
onset
septic
shock
obtain
use
methodolog
data
recent
publish
horizont
line
indic
geometr
mean
dot
line
indic
refer
rang
healthi
subject
pvalu
calcul
use
unpair
ttest
logtransform
data
bf
kinet
mhladr
express
circul
creactiv
protein
procalcitonin
leukocyt
number
ferritin
patient
individu
data
shown
transpar
grey
line
repres
mean
panel
b
c
e
geometr
mean
panel
c
e
valu
entir
cohort
transpar
pink
line
panel
b
repres
data
obtain
geometr
mean
ci
pleas
note
valu
obtain
day
onset
septic
shock
plot
day
respect
dot
line
panel
b
indic
refer
rang
healthi
subject
pvalu
next
transpar
grey
line
repres
chang
time
patient
calcul
use
mix
model
analysi
log
transform
data
panel
f
differ
sepsi
patient
panel
b
analys
use
unpair
ttest
logtransform
data
p
day
day
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
